… And Heart Drug With Theravance | Chemical & Engineering News
Volume 90 Issue 43 | p. 23 | Concentrates
Issue Date: October 22, 2012

… And Heart Drug With Theravance

Department: Business
Keywords: small molecule, cardiovascular, hypertension

Merck & Co. and Theravance have formed a partnership to discover, develop, and commercialize small molecules directed at targets being investigated for their involvement in hypertension and heart failure. Merck will make an up-front payment of $5 million, gaining an exclusive license to Theravance’s therapeutic candidates. Theravance is eligible to receive additional milestone payments of up to $148 million for the first indication, as well as royalties.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment